心脏辅助设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品(主动脉内球囊泵、全人工心脏和心室辅助装置)和地理细分

市场快照

Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在过去几年中,对心脏辅助装置的需求有所增加,因为这些装置有助于血液持续流向心脏,并且不需要机械轴承。它还充当移植的桥梁,提供微型尺寸,并且是心脏病患者的生命线支持,帮助他们从心脏移植中恢复或等待心脏移植。2015 年 3 月,美国 FDA 批准了 Impella 2.5 系统,该系统可帮助患者在某些高危经皮冠状动脉介入治疗 (HRPCI) 手术中维持稳定的心脏功能和循环。随着技术的进步,可靠的心室辅助装置 (VAD) 的种类越来越多,有望为患者提供更好的治疗选择。此外,

预计老年人口增加和心脏病患病率增加等其他因素将在预测期内推动市场。

报告范围

根据报告的范围,辅助装置被定义为一种与心脏一起工作的机械泵,以提高泵送效率并保持整个身体的最佳血液流动。心脏辅助装置用于治疗终末期心力衰竭,由个人的需要决定。

By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
Left Ventricular Assist Device
Right Ventricular Assist Device
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计总人工心脏部分将在预测年份显示出更好的增长

按产品分为主动脉内球囊泵、全人工心脏和心室辅助装置。心脏移植是终末期心力衰竭最有效的治疗方法。在全球范围内,对供体器官的需求有所增加。根据美国卫生与公众服务部的数据,2018 年约有 17,553 名捐赠者。此外,市场对人工心脏的需求呈指数增长。据估计,仅在美国,每天就有近 4,000 人等待捐赠者的心脏。全人工心脏被认为是晚期心力衰竭患者的长期解决方案。目前,市场上有许多不同类型的人工心脏正在使用:SynCardia 临时全人工心脏和 Abiocar 人工心脏。因此,这些产品的可用性预计将推动全球市场。

Cardiac Assist Devices Market 1

北美主导心脏辅助设备市场

由于技术的进步和心脏病负担的增加,北美地区是该市场的主要贡献者之一。根据疾病控制和预防中心 (CDC) 的数据,每年约有 647,000 名美国人 死于心脏病。越来越多的心脏病患者导致了更高的需求。全球 30% 以上的 LVAD 植入物在美国进行,并且植入物的数量逐年增加。因此,这些设备的高采用率预计将在预测期间显着增加心脏辅助设备市场。

Cardiac Assist Devices Market 2

竞争格局

心脏辅助设备市场的全球参与者包括雅培、Abiomed Inc.、Berlin Heart GmbH、BiVACOR Inc.、Braile Biomedica Ltd、Getinge AB、Jarvik Heart Inc.、Medtronic PLC、SynCardia Systems, LLC 和 Teleflex Incorporated。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Heart Disease Prevalence

      2. 4.2.2 Rising Geriatric Population

      3. 4.2.3 Technological Advancement

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatments like Pacemakers

      2. 4.3.2 Risk Associated with Device Implantation

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Intra-aortic Balloon Pump

      2. 5.1.2 Total Artificial Heart

      3. 5.1.3 Ventricular Assist Device

        1. 5.1.3.1 Left Ventricular Assist Device

        2. 5.1.3.2 Right Ventricular Assist Device

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Abiomed Inc.

      3. 6.1.3 Berlin Heart GmbH

      4. 6.1.4 BiVACOR Inc.

      5. 6.1.5 Braile Biomedica Ltd

      6. 6.1.6 Getinge AB

      7. 6.1.7 Jarvik Heart Inc.

      8. 6.1.8 Medtronic PLC

      9. 6.1.9 SynCardia Systems, LLC

      10. 6.1.10 Teleflex Incorporated

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cardiac Assist Devices Market market is studied from 2018 - 2026.

The Cardiac Assist Devices Market is growing at a CAGR of >7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Laboratories, BiVACOR Inc., Getinge AB, Medtronic PLC, Teleflex Incorporated are the major companies operating in Cardiac Assist Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!